TGFB1 and hepatocellular carcinoma: To get into clinical insights, the authors treated HCC cell lines Huh7 and HepG2 with Transforming growth factor-beta 1 (TGF-β1) to induce higher expression of EMT-associated proteins and observed reduced LINC00261 expression [19].